Quality of life in Japanese female patients with systemic lupus erythematosus: Evaluation using the Short Form 36 Health Survey

References

• Grootscholten C, Ligtenberg G, Derksen R, Schreurs KM, de Glas-Vos JW, Hagen EC, et al. Health-related quality of life in patients with systemic lupus erythematosus: a lupus specific symptom checklist. Qual Life Res. 2003;12(6):635–44.
   PubMed Web of Science ®Google Scholar
• Lash AA. Quality of life in systemic lupus erythematosus. Appl Nurs Res. 1998;11(3):130–7.
   PubMed Web of Science ®Google Scholar
• WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–9.
   PubMed Web of Science ®Google Scholar
• Khanna S, Pal H, Pandey RM, Handa R. The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology (Oxford). 2004;43(12):1536–40.
   PubMed Web of Science ®Google Scholar
• Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Scand J Rheumatol. 2009;38(2):121–7.
   PubMed Web of Science ®Google Scholar
• Navarrete-Navarrete N, Perelta-Ramírez MI, Sabio JM, Martinéz-Egea I, Santos-Ruiz A. Quality-of-life predictor factors in patients with SLE and their modification after cognitive behavioural therapy. Lupus. 2010;19(14):1632–9.
   PubMed Web of Science ®Google Scholar
• Freire E, Maia I, Nepomuceno J, Ciconelli RM. Damage index assessment and quality of life in systemic lupus erythematosus patients (with long-term disease) in Northeastern Brazil. Clin Rheumatol. 2007;26(3):423–8.
   PubMed Web of Science ®Google Scholar
• Thumboo J. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol. 2000;27(6): 1414–20.
   PubMed Web of Science ®Google Scholar
• Nandini Moorthy L, Robbins L, Harrison MJ, Peterson MG, Cox N, Onel KB, Lehman TJ. Quality of life in paediatric lupus. Lupus. 2004;13(4):234–40.
   PubMed Web of Science ®Google Scholar
• Funauchi M, Tamaki C, Yamagata T, Nozaki Y, Ikoma S, Sugiyama M, et al. Quality of life in patients with systemic lupus erythematosus- Preliminary survey using a short questionnaire (In Japanese). Jpn J Clin Immunol. 2005;28(1):40–7.
   PubMedGoogle Scholar
• Ishiguro M, Hashizume H, Ikeda T, Yamamoto Y, Furukawa F. Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesion in Japan. Lupus. 2014;23(1):93–101.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Urowitz MB, Gough J, MacKinnon A. Fibromyalgia is a Major Contributor to Quality of Life in Lupus. J Rheumatol. 1997;24(11):2145–8.
   PubMed Web of Science ®Google Scholar
• McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus. 2006;15(10):633–43.
   PubMed Web of Science ®Google Scholar
• Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol.2001;28(3):525–32.
   PubMed Web of Science ®Google Scholar
• Appenzeller S, Clarke AE, Panopalis P, Joseph L, St Pierre Y, Li T. The relationship between renal activity and quality of life in systemic lupus erythematosus. J Rheumatol. 2009;36(5):947–52.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthrisis Rheum. 1992;35(6):630–40.
   PubMed Web of Science ®Google Scholar
• Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363–9.
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Suzukamo Y. Manual of SF-36v2 Japanese version: Institute for Health Outcomes & Process Evaluation Research, Kyoto, 2004.
   Google Scholar
• Ware JE, Kosinski M, Dewey JE. How to Score Version Two of the SF-36 Health Survey. Lincoln, RI: QualityMetric, Incorporated, 2000
   Google Scholar
• Paralta-Ramírez MI, Jiménez-Alonso J, Godoy-García JF, Pérez-Garcia M; Grop Lupus Virgen de las Nieves. The effects of daily stress and stressful life events on the clinical symptomatology of patients with lupus erythematosus. Psychosom Med. 2004;66(5): 788–94.
   PubMed Web of Science ®Google Scholar
• Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Rev Pharmacoecon Outcomes Res.2005;5(3): 317–26.
   PubMedGoogle Scholar
• Strand V. Issues in drug development in SLE: clinical trial design, outcome measures and biomarkers. In: Wallece DJ, Hahn BH (eds), Dubois’ lupus erythematosus. Los Angeles: Williams & Wilkins; 1997.
   Google Scholar
• Strand V, Petri M, Buyon J, Joh T, Chevrier M, Freimuth W. Baseline data from 5 randomized controlled trials (RCTs) demonstrate that systemic lupus erythematosus (SLE) impacts all domains of health-related quality of life (HRQoL). Arthritis Rheum. 2006;329(17):S277.
   Google Scholar
• Gladman DD, Urowitz MB, Ong A, Gough J, Mackinnin A. Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol. 1996;14(3):305–8.
   PubMed Web of Science ®Google Scholar
• Jolly M, Utset RO. Can disease specific measures for systemic lupus erythematosus predict patients’ health related quality of life. Lupus. 2004;13(12):924–6.
   PubMed Web of Science ®Google Scholar
• Valencia-Flores M, Cardiel MH, Santiago V, Resendiz M, Castaño VA, Negrete O, et al. Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus. Lupus. 2004;13(1):4–10.
   PubMed Web of Science ®Google Scholar
• Gudbjörnsson B, Hetta J. Sleep disturbances in patients with systemic lupus erythematosus: A questionnaire-based study. Clin Exp Rheumatol. 2001;19(5):509–14.
   PubMed Web of Science ®Google Scholar
• Kasitanon N, Achsavalertsak U, Maneeton B, Wangkaew S, Puntana S, Sukitawut W, Louthrenoo W. Associated factors and psychotherapy on sleep disturbances in systemic lupus erythematosus. Lupus. 2013;22(13):1353–60.
   PubMed Web of Science ®Google Scholar
• Chandrasekhara PK, Jayachandran NV, Rajasekhar L, Tomas J, Narsimulu G. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol. 2009;19(4):407–15.
   PubMed Web of Science ®Google Scholar
• Costa DD, Bernatsky D, Drista M, Clarke AE, Dasqupta K, Keshani A, Pineau C. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum. 2005;53(2):272–8.
   PubMed Web of Science ®Google Scholar
• Greenwood KM, Lederman L, Lindner HD. Self-reported sleep in systemic lupus erythematosus. Clin Rheumatol. 2008;27(9):1147–51.
   PubMed Web of Science ®Google Scholar
• Iaboni A, Ibanez D, Gladman DD, Urowitz MB, Moldofsky H. Fatigue in systemic lupus erythematosus: Contributions of disordered sleep, sleepiness, and depression. J Rheumatol. 2006;33(12):2453–7.
   PubMed Web of Science ®Google Scholar
• Kozora E, Ellison MC, Waxmonsky JA, Wamboldt FS, Patterson TL. Major life stress, coping styles and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus. 2005;14(5):363–72.
   PubMed Web of Science ®Google Scholar
• Tench CM, McCurdle I, White PD, D’Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000;39(11):1249–54.
   PubMed Web of Science ®Google Scholar
• Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Prac. 2006;81(10):1361–7.
   PubMed Web of Science ®Google Scholar
• Obal F, Opp M, Cady AB, Johannsen L, Postlethwaite AE, Poppleton HM, et al. Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic. Am J Physiol. 1990;259(3 Pt 2):R439–46.
   PubMed Web of Science ®Google Scholar
• Moldofski H, Lue FA, Eisen J, Keystone E, Gorczynski RM. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med. 1986;48(5):309–18.
   PubMed Web of Science ®Google Scholar
• Reichlin S. Neuroendocrine-immune interactions. N Engl J Med. 1993;21:1246–53
   Google Scholar
• Valencia-Flores M, Resendiz M, Castãno VA, Santiago V, Campos RM, Sandino S, et al. Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum. 1999; 42(10):2189–93.
   PubMed Web of Science ®Google Scholar
• Stoll T, Kauer S, Büchi S, Klaghofer R, Sensky T, Villiger PM. Prediction of depression in systemic lupus erythematosus patients using SF-36 Mental Health scores. Rheumatology (Oxford). 2001;40(6):695–8.
   PubMed Web of Science ®Google Scholar
• Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, Panopalis P. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum. 2007;57(1):56–63.
   PubMed Web of Science ®Google Scholar
• Partridge AJ, Karlson EW, Daltroy LH, Lew RA, Wright EA, Fossel AH, et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum. 1997;40(12):2199–206.
   PubMed Web of Science ®Google Scholar
• Panopalis P, Julian L, Yazdany J, Gillis JZ, Trupin L, Hersh A, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Rheum. 2007;57(8): 1453–60.
   PubMed Web of Science ®Google Scholar
• Bertoli AM, Fernández M, Alarcón GS, Vilá LM, Reveille JD, et al. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis. 2007;66(1):12–17.
   PubMed Web of Science ®Google Scholar
• Utset TO, Fink J, Doninger NA. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol. 2006;33(3): 531–8.
   PubMed Web of Science ®Google Scholar
• Lacaille D. Arthritis and employment research. Where are we? Where do we need to go? J Rheumatol Suppl. 2005;72:42–5.
   PubMedGoogle Scholar
• Baker K, Pope J, Fortin P, Silverman E, Peschken C; 1000 Faces of Lupus Investigators; et al. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus.2009;18(14):1281–8.
   PubMed Web of Science ®Google Scholar
• Mok CC, Cheung MY, Ho LY, Yu KL, To CH. Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus. 2008;17(12):1103–7.
   PubMed Web of Science ®Google Scholar
• Sakai T, Kogiso M. Soy isoflavones and immunity. J Med Invest. 2000;55(3–4):167–73.
   Google Scholar
• Zhang R, Li Y, Wang W. Enhancement of immune function in mice fed high doses of soy daidzein. Nutr Cancer. 1997;29(1): 24–8.
   PubMed Web of Science ®Google Scholar
• Mahammadshahi M, Haidari F, Saei AA, Rashidi B, Mahboob S, Rashidi MR. Soy protein, genistein, and daidzein improve serum paraoxonase activity and lipid profiles in rheumatoid arthritis in rats. J Med Food. 2013;16(2):147–54.
   PubMed Web of Science ®Google Scholar